In a landmark shift for consumer genomics, Anne Wojcicki, the co-founder and former CEO of 23andMe, has announced the ...

After the company filed for bankruptcy in March, this week, the sale of 23andMe was completed after previously being approved by a judge.

DNA from 23andMe after it declared bankruptcy. Now the more than 10 million remaining customers should delete theirs, too.

TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and founded and led by Anne ...

That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s assets for $305 million. The transaction — which arrives more than three ...

Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.

The DNA data of millions of people who used 23andMe's services won't be sold to a pharmaceutical company. A bankruptcy judge greenlighted the sale of the remnants of the firm, including its wealth of ...

A bankruptcy court gave the green light for TTAM Research Institute - a firm launched by 23andMe's co-founder and former CEO ...

A bankruptcy judge approved the sale of 23andMe's assets and business operations to a nonprofit led by 23andMe’s co-founder ...

TTAM Research Institute, a nonprofit medical research company led by 23andMe founder and former CEO Anne Wojcicki, is set to purchase genetic data and other assets for $305 million under the approved ...

TTAM Research Institute is set to buy the company's Personal Genome Service, Research Service and Lemonaid Health business for $305 million after winning the final round of bidding to buy the ...

That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s assets for $305 million.